Dr. Rainer Hubmann | Biomedical and Healthcare Applications | Best Researcher Award

Doctorate at Red Cross | Austria

Mag. Dr. Rainer Hubmann embarked on his academic journey at the University of Vienna, earning his master’s degree in Biology/Genetics in 1996. During this time, he became an active member of the Cell Cycle Club under the leadership of Kim Nasmyth at the Research Institute of Molecular Pathology (IMP). His passion for molecular biology led him to pursue his Ph.D. at the Medical University of Vienna, where he focused on the regulation of CD23 in Chronic Lymphocytic Leukemia (CLL), completing it in 2002.

Professional Profiles

Scopus

Orcid

🎓Education and Academic Background

Dr. Rainer Hubmann’s distinguished academic journey began at the University of Vienna, where he earned a Master’s degree in Biology and Genetics (1987–1996). During this time, he joined the prestigious Cell Cycle Club, led by Kim Nasmyth, sharpening his focus on cell cycle research. He pursued his Ph.D. thesis (1997–2002) at the Medical University of Vienna (MUW), investigating the Regulation of CD23 in Chronic Lymphocytic Leukemia (CLL). His postdoctoral work from 2002 to 2011 extended into pioneering studies on NOTCH2 regulation and the characterization of CLL stem cells. In 2022, he assumed the role of Group Leader and Senior Scientist at the Division of Hematology and Hemostaseology, MUW, further solidifying his leadership in hematological research.

🔬 Research and Innovation

Dr. Hubmann’s research has made groundbreaking strides in NOTCH signaling and its implications in cancer. His work elucidates the central role of NOTCH2 signaling in CLL leukemogenesis, uncovering vital mechanisms of disease progression. He has identified GLIOTOXIN as a potent therapeutic NOTCH2/CSL transactivation inhibitor, presenting it as a promising alternative to conventional γ-secretase inhibitors. Furthermore, he discovered a tumor-suppressor role for NOTCH3 signaling in CLL, revealing its therapeutic potential. Dr. Hubmann’s studies have highlighted the recurring NOTCH2ΔNRR gain-of-function (GOF) mRNA deletions as potentially disease-defining genetic lesions in CLL. His innovative research also explores somatic recombination involving ancient and recent NOTCH2 gene variants, addressing hereditary, geographic, and gender-based variations.

🧪 Patents and Innovations

Dr. Hubmann’s contributions to translational medicine are protected by several patents. These include Gliotoxin for the treatment of NOTCH2-associated malignancies (WO/2006/135949; US Patent No 7,981,878) and NOTCH21A01/1a4-RFLP as a leukemia/tumor predisposition detection tool (MUW Tech-ID: 835.19). His patented innovations underscore his role in translating basic research into clinical applications.

💡 Technical Expertise

Dr. Hubmann possesses advanced technical skills pivotal to hematology and oncology research. His expertise includes gene expression and silencing techniques such as retroviral vectors and siRNA-mediated gene silencing. He is proficient in molecular analysis, including RT-PCR, Northern & Western blotting, and RNA-seq sequence analysis. His work extends to drug screening models, xenograft mouse models, and developing diagnostic tools for personalized medicine. His ability to blend bioinformatics with preclinical studies further enhances his contributions to the field.

💵 Funding and Grants

Over his career, Dr. Hubmann has secured significant funding for his research. Notable grants include FWF P15100 (2001) for studying the Regulation and Function of NOTCH2 in CLL, and ÖNB Jubiläumsfonds (2002, 2004) for exploring NOTCH2 in leukemogenesis. His work on GLIOTOXIN’s therapeutic potential was supported by Initiative Krebsforschung (2013), while his recent studies on NOTCH2ΔNRR deletions were funded by the Fellinger Krebsforschungsfonds (2022). These funding milestones reflect the impact and importance of his research.

🏆 Awards and Recognition

Dr. Hubmann’s outstanding contributions to medical research have earned him numerous accolades. In 1999, he received the Aventis Stiftung Award for his work on fibroblast growth factor in Hairy Cell Leukemia. His innovative findings on interferon-alpha in Hairy Cell Leukemia earned the Erste Bank Preis in 2001. In 2005 and 2010, he was awarded the Sanofi-Aventis Prize for breakthroughs in cancer therapy and PI3-K/Akt/CK2 signaling. Additionally, the Paracelsus Medical University Award (2008) recognized his research on TGF-β in Radon therapy for Ankylosing Spondylitis patients.

🏢 Professional Memberships

Dr. Hubmann is an esteemed member of the Austrian Society for Hematology and Oncology (ÖGHO). He serves as the Vice Coordinator of the Comprehensive Cancer Center Vienna (CCC) Research Cluster, focusing on Microenvironment, Vasculature, and Metastasis, underscoring his leadership in advancing cancer research.

🎓 Teaching and Mentorship

Since 1998, Dr. Hubmann has played a pivotal role in teaching and mentoring young scientists. He leads specialized courses, including Molecular Biology in Hematology-Oncology and Clinical and Experimental Hematology, since 2001. His dedication extends to supervising Ph.D. and diploma students, nurturing the next generation of researchers and clinicians.

Publications Top Noted📚

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL Cells

Authors: Rainer Hubmann

Journal: Cells

Year: 2020

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

Authors: Rainer Hubmann

Journal: British Journal of Cancer

Year: 2020

Combined approach for characterization and quality assessment of rabbit bone marrow-derived mesenchymal stem cells intended for gene banking

Authors: Rainer Hubmann

Journal: New Biotechnology

Year: 2020

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Authors: Rainer Hubmann

Journal: Nature Chemical Biology

Year: 2019

Critical assessment of the efficiency of CD34 and CD133 antibodies for enrichment of rabbit hematopoietic stem cells

Authors: Rainer Hubmann

Journal: Biotechnology Progress

Year: 2018

Early Academic Pursuits

Dr. Yongkang Lyu's academic journey began in earnest with his enrollment at Shandong Normal University in 2017, where he pursued a Bachelor of Science in Physics. During this period, Lyu demonstrated a profound commitment to both academic excellence and community service. He served as the editor of the college public account from 2017 to 2021, a role that involved managing content, coordinating contributions, and enhancing the visibility of the college's activities and achievements. His dedication extended beyond the confines of the university as he volunteered at the library from 2017 to 2019 and participated in volunteer education programs in western China, underscoring his commitment to education and community development.

Professional Endeavors

Dr. Yongkang Lyu's professional journey is marked by a blend of teaching and hands-on technical roles. In 2020, he gained practical teaching experience at Linqing Foreign Language Middle School in Shandong Province, where he applied his physics knowledge in an educational setting. From 2021 to 2023, he served as a graduate entrance examination professional course teacher, specializing in quantum mechanics, electromagnetism, optics, electrodynamics, thermodynamics, and statistical mechanics. His current role as a Lab Manager at Shandong Normal University, which he has held since 2021, involves overseeing lab operations, configuring high-performance computing servers, and maintaining Linux-based computational chemistry environments. Lyu's technical proficiency extends to the setup and maintenance of advanced computational tools and software, highlighting his versatile skill set.

Contributions and Research Focus

Dr. Yongkang Lyu's research is characterized by the integration of quantum chemistry, first-principles calculations, and molecular dynamics to conduct multi-scale simulations and analyses. His work spans a variety of fields, including biology, environmental science, materials science, chemical engineering, and energy. Notably, his research projects have focused on:

Martini Coarse-Grained Force Field Simulations: Lyu has conducted simulations on multi-component phospholipid membranes to investigate the transmembrane mechanisms of peptides and the dynamic properties of membrane structures under external electric field driving. This research provides mechanistic analysis from both physical and morphological perspectives, offering theoretical guidance for drug design and pathology research.

All-Atom Force Field Simulations: He has studied the dynamic processes of natural and artificial nucleic acid molecules adsorbed on graphene biosensors. By combining quantum chemistry calculations and wave function analysis, Lyu has explored changes in electronic structure and interaction nature due to adsorption, contributing valuable insights to the field of biosensing.

Artificial Bee Colony Algorithm: Lyu has employed this algorithm for hierarchical precise conformational searches, studying the electronic structure characteristics of the lowest free energy conformations of dinitrophenol clusters in solvents. His work reveals interaction features of different solvent coordination numbers through wave function analysis and analyzes changes in infrared vibrational spectra.

Accolades and Recognition

Throughout his academic and professional career, Dr. Yongkang Lyu has been recognized for his contributions to both education and research. His role as an editor of the college public account and his volunteer work have earned him commendations for his leadership and commitment to community service. In the realm of research, his innovative approaches and significant findings in computational chemistry have garnered respect and acknowledgment from his peers and mentors alike.

Impact and Influence

Dr. Yongkang Lyu's work has had a substantial impact on multiple scientific fields. His research in computational chemistry and molecular dynamics provides critical insights that bridge physical methods and chemical theories, influencing areas such as drug design, pathology, and biosensing. His educational endeavors, particularly his teaching roles, have inspired and equipped students with a deep understanding of complex scientific concepts.

The Biomedical Award is a prestigious honor conferred upon individuals who have made significant contributions to the field of biomedical science. This accolade recognizes groundbreaking research, innovative technologies, and exceptional advancements that have a profound impact on healthcare and medical practices. Established to highlight excellence in biomedical research, the award serves as a testament to the dedication and ingenuity of scientists and researchers worldwide.

Legacy and Future Contributions

As Dr. Yongkang Lyu continues his Doctor of Science in Atomic and Molecular Physics at Shandong Normal University, his ongoing research and professional activities are poised to leave a lasting legacy. His current and future contributions are expected to advance the understanding of molecular interactions and dynamics, with potential applications in developing new technologies and therapeutic strategies. Lyu's commitment to combining theoretical and practical approaches ensures that his work will continue to influence and inspire future generations of scientists and educators.

In summary, Dr. Yongkang Lyu's academic pursuits, professional endeavors, and research focus reflect a remarkable blend of technical proficiency, innovative research, and community engagement. His contributions to science and education are noteworthy, and his future work promises to further advance the fields of computational chemistry and molecular physics.